Terumo Revenue 2012-2019 | TRUMY

Terumo annual/quarterly revenue history and growth rate from 2012 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Terumo revenue for the quarter ending December 31, 2019 was $M, a 100% decline year-over-year.
  • Terumo revenue for the twelve months ending December 31, 2019 was $3.958B, a 10.4% decline year-over-year.
  • Terumo annual revenue for 2020 was $5.786B, a 7.24% increase from 2019.
  • Terumo annual revenue for 2019 was $5.395B, a 1.99% increase from 2018.
  • Terumo annual revenue for 2018 was $5.29B, a 10.63% increase from 2017.
Terumo Annual Revenue
(Millions of US $)
2020 $5,786
2019 $5,395
2018 $5,290
2017 $4,782
2016 $4,358
2015 $4,476
2014 $4,674
2013 $4,868
2012 $4,911
Terumo Quarterly Revenue
(Millions of US $)
2019-12-31
2019-06-30 $1,388
2018-06-30 $1,316
2017-06-30 $1,254
2016-06-30 $1,158
2015-06-30 $1,055
2015-03-31 $1,061
2014-12-31 $1,143
2014-09-30 $1,136
2014-06-30 $1,123
2014-03-31 $1,221
2013-12-31 $1,192
2013-09-30 $1,161
2013-06-30 $1,122
2013-03-31 $1,289
2012-12-31 $1,278
2012-09-30 $1,219
2012-06-30 $1,198
2012-03-31 $1,242
2011-12-31 $1,267
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $30.252B $5.786B
Terumo Corporation is engaged in the manufacture and sales of medical products and equipment. The products offered by the Company covers General Hospital Products, Cardiac & Vascular Products, Blood Transfusion Products and Consumer Healthcare Products. General hospital products offered by it include Disposable Medical Equipment, Medical Electronic Products, Diabetes Care Products, CAPD Systems and Pharmaceuticals; Cardiac & Vascular Products include Interventional Systems, Cardiovascular Systems and Artificial Vascular Grafts. Terumo's Blood Transfusion products include blood bags, blood filter, filter in line, blood administration sets and apheresis, while consumer healthcare products include ear thermometer, electronic thermometer, basal body thermometer, electronic sphygmomanometer, urine test strip and leg compression stockings. Terumo Corporation is headquartered in Tokyo, Japan.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $192.284B 34.44
Medtronic (MDT) Ireland $150.740B 30.64
Stryker (SYK) United States $86.808B 32.49
Boston Scientific (BSX) United States $48.184B 28.28
Lonza Group Ag (LZAGY) Switzerland $45.932B 0.00
Baxter (BAX) United States $38.572B 23.16
EssilorLuxottica Societe Anonyme (ESLOY) France $33.144B 0.00
ResMed (RMD) United States $30.665B 41.49
Zimmer Biomet Holdings (ZBH) United States $30.283B 24.93
Sunny Optical Technology (SNPTF) China $21.586B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $17.729B 0.00
Insulet (PODD) United States $17.311B 596.75
Bio-Rad Laboratories (BIO) United States $16.624B 63.04
DiaSorin S.p.A (DSRLF) Italy $11.581B 0.00
GN STORE NORD (GNNDY) Denmark $10.027B 51.11
Canopy Growth (CGC) Canada $9.920B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $9.045B 0.00
William Demant Holdings (WILYY) Denmark $8.605B 0.00
Quidel (QDEL) United States $7.949B 19.81
Perrigo (PRGO) Ireland $6.613B 11.65
Hill-Rom Holdings (HRC) United States $6.425B 17.39
Haemonetics (HAE) United States $5.715B 41.53
Envista Holdings (NVST) United States $4.800B 32.33
GW Pharmaceuticals (GWPH) United Kingdom $4.261B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.072B 0.00
ICU Medical (ICUI) United States $3.965B 29.76
Neogen (NEOG) United States $3.964B 64.99
TG Therapeutics (TGTX) United States $3.696B 0.00
National Vision Holdings (EYE) United States $3.462B 90.92
Agios Pharmaceuticals (AGIO) United States $3.223B 0.00
DFB Healthcare Acquisitions (AHCO) United States $3.179B 161.23
NanoString Technologies (NSTG) United States $2.407B 0.00
NuVasive (NUVA) United States $2.384B 34.43
Aphria (APHA) Canada $2.284B 0.00
AtriCure (ATRC) United States $1.946B 0.00
Owens & Minor (OMI) United States $1.900B 20.03
InMode (INMD) Israel $1.433B 32.24
Cardiovascular Systems (CSII) United States $1.392B 0.00
Quanterix (QTRX) United States $1.390B 0.00
Aurora Cannabis (ACB) Canada $1.378B 0.00
MacroGenics (MGNX) United States $1.331B 0.00
BioLife Solutions (BLFS) United States $1.145B 1166.33
Cerus (CERS) United States $1.135B 0.00
Lantheus Holdings (LNTH) United States $0.900B 16.02
OraSure Technologies (OSUR) United States $0.884B 0.00
PetIQ (PETQ) United States $0.834B 47.64
BellRing Brands (BRBR) United States $0.822B 34.75
Meridian Bioscience (VIVO) United States $0.818B 17.75
Omeros (OMER) United States $0.776B 0.00
LeMaitre Vascular (LMAT) United States $0.763B 40.31
Phibro Animal Health (PAHC) United States $0.741B 15.79
Varex Imaging (VREX) United States $0.647B 183.33
Vapotherm (VAPO) United States $0.644B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.609B 43.24
HEXO (HEXO) $0.517B 0.00
Surmodics (SRDX) United States $0.516B 315.83
Zynex (ZYXI) United States $0.467B 43.35
Viemed Healthcare (VMD) United States $0.375B 13.32
Cytosorbents (CTSO) United States $0.357B 0.00
Surface Oncology (SURF) United States $0.334B 0.00
InfuSystems Holdings (INFU) United States $0.332B 46.83
Utah Medical Products (UTMD) United States $0.319B 29.09
Organigram Holdings (OGI) Canada $0.297B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.257B 0.00
Bovie Medical (APYX) United States $0.254B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.225B 0.00
Chimerix (CMRX) United States $0.222B 0.00
Wound Management Technologies (SMTI) United States $0.217B 0.00
Female Health (VERU) United States $0.212B 0.00
Exagen (XGN) United States $0.180B 0.00
Liberty Health Sciences (LHSIF) United States $0.133B 0.00
Chembio Diagnostics (CEMI) United States $0.131B 0.00
Evolus (EOLS) United States $0.124B 0.00
Fonar (FONR) United States $0.122B 17.89
Green Organic Dutchman Holdings (TGODF) Canada $0.111B 0.00
Rockwell Medical (RMTI) United States $0.100B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Capricor Therapeutics (CAPR) United States $0.085B 0.00
MTech Acquisition (KERN) United States $0.073B 0.00
Brainsway (BWAY) Israel $0.070B 0.00
United-Guardian (UG) United States $0.066B 15.94
Nephros (NEPH) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
Myomo (MYO) United States $0.034B 0.00
GUARDION HEALTH (GHSI) United States $0.026B 0.00
FSD PHARMA INC (HUGE) Canada $0.023B 0.00
NF Energy Saving (BIMI) China $0.022B 0.00
Akers Biosciences Inc (AKER) United States $0.018B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.016B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Senestech (SNES) United States $0.007B 0.00
Trinity Biotech (TRIB) Ireland $0.000B 8.17